Lipoxin B4
Lipoxin B4 (LXB4) is a structurally distinct product of arachidonic acid metabolism. Lipoxin B4 reduces leukocyte infiltration and mucus secretion in the nasal mucosa and decreases mast cell and eosinophil degranulation in the upper airway. Lipoxin B4 decreases airway inflammation, mucus metaplasia and hyper- responsiveness in the lower airway. Lipoxin B4 shows mucosal protective actions and has the potential for the research of allergic inflammation in the upper and lower airways[1].
Product Specifications
CAS Number
98049-69-5
Product Name Alternative
LXB4
UNSPSC
12352211
Hazard Statement
H315-H319-H335
Target
Endogenous Metabolite
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/lipoxin-b4.html
Concentration
283.71 μM * 250 μL in Ethanol
Purity
99.20
Solubility
10 mM in DMSO
Smiles
CCCCC[C@H](O)[C@H](O)/C=C/C=C/C=C\C=C\[C@@H](O)CCCC(O)=O
Molecular Formula
C20H32O5
Molecular Weight
352.47
Precautions
P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P362+P364-P403+P233-P405-P501
References & Citations
Shipping Conditions
Blue Ice
Storage Conditions
Solution, -20°C, 2 years
Scientific Category
Natural Products
Clinical Information
No Development Reported
Isoform
Human Endogenous Metabolite
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
LMO2 (B-Cell Marker) (LMO2/1971), CF568 conjugate, 0.1mg/mL
Recombinant Human S100A6 Protein (Baculovirus, His Tag)
